Market Tracker

11/26 6:05pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.11
Data as of 4:02pm ET
 +0.01 / +0.48%
Today’s Change
1.86
Today|||52-Week Range
5.30
-45.76%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close2.10
Today’s open2.08
Day’s range2.02 - 2.14
Volume128,432
Average volume (3 months)460,839
Market cap$193.9M
Dividend yield--
Data as of 4:02pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--Wang On Group Ltd-0.00-6.90%
SZYMSolazyme Inc+0.03+1.15%
AGENAgenus Inc+0.04+1.35%
PSTIPluristem Therapeuti...+0.03+1.16%
Data as of 4:00pm ET, 11/26/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts